We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,010 results
  1. Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy

    Background

    There is room for improvement of prevention of venous thromboembolism (VTE) after lower-leg cast application or knee arthroscopy....

    Carolina E. Touw, Banne Nemeth, ... Suzanne C. Cannegieter in Thrombosis Journal
    Article Open access 28 April 2023
  2. Sex-dependent balance between thrombin and plasmin generation in the presence of thrombomodulin

    Background: Assessing simultaneous generation of thrombin (TG) and plasmin (PG) is an approach to evaluate the balance between coagulation and...

    Ivan D. Tarandovskiy, Paul W. Buehler, Elena Karnaukhova in Journal of Thrombosis and Thrombolysis
    Article 12 December 2022
  3. Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma

    Patients with hemophilia A (PwHA) may have concurrent deficiency of representative anticoagulant proteins, protein (P)C, PS, and antithrombin (AT),...

    Koji Yada, Kenichi Ogiwara, ... Keiji Nogami in International Journal of Hematology
    Article 19 December 2023
  4. Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma

    The issue of how to identify newly diagnosed multiple myeloma (NDMM) patients requiring thromboprophylaxis remains unsolved. Several changes in...

    Diego Velasco-Rodríguez, Inés Martínez-Alfonzo, ... Pilar Llamas-Sillero in Journal of Thrombosis and Thrombolysis
    Article 11 January 2023
  5. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives

    Purpose of the Review

    Thrombotic risk assessment in antiphospholipid positive (aPL +) subjects is a major challenge, and the study of in vitro...

    Thomas Foret, Virginie Dufrost, ... Denis Wahl in Current Rheumatology Reports
    Article 19 February 2024
  6. Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background

    Background

    The current study aims to identify the relationships between coagulation factors and plasma thrombin generation in a large population-based...

    Pauline C. S. van Paridon, Marina Panova-Noeva, ... Henri M. H. Spronk in Thrombosis Journal
    Article Open access 08 June 2022
  7. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19

    Patients with Coronavirus Disease-2019 (COVID‐19) have haemostatic dysfunction and are at higher risk of thrombotic complications. Although age is a...

    Marco G. Mennuni, Roberta Rolla, ... Giuseppe Patti in Journal of Thrombosis and Thrombolysis
    Article Open access 10 June 2021
  8. The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study

    Background

    Cardiac surgery with cardiopulmonary bypass (CPB) is associated with coagulopathic bleeding. Impaired thrombin generation may be an...

    Justyna Bartoszko, Han Li, ... Keyvan Karkouti in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
    Article 22 December 2021
  9. Titrated versus conventional anticoagulation management for thrombin generation in cardiac surgery: a randomized controlled trial

    Purpose

    Optimal heparin titration during cardiopulmonary bypass (CPB) may reduce coagulation system activation and preserve hemostatic function...

    Han Li, Justyna Bartoszko, ... Keyvan Karkouti in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
    Article 08 July 2022
  10. Thrombin Generation in Trauma Patients: How Do we Navigate Through Scylla and Charybdis?

    Purpose of Review

    Coagulopathy is a complex pathological condition manifested through the insufficient or excessive tendency to form blood thrombi,...

    Alexander Y. Mitrophanov, Kofi Vandyck, Kenichi A. Tanaka in Current Anesthesiology Reports
    Article Open access 24 January 2022
  11. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements

    Background

    Thrombin generation (TG) assessed by Calibrated Automated Thrombogram (CAT-I) reflects the overall capacity of plasma to generate thrombin,...

    P. L. A. Giesen, A. J. W. Gulpen, ... H. M. H. Spronk in Thrombosis Journal
    Article Open access 28 August 2021
  12. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19

    Thrombin is a trypsin-like serine protease with multiple physiological functions. Its role in coagulation and thrombosis is well-established....

    Kholoud F. Aliter, Rami A. Al-Horani in Cardiovascular Drugs and Therapy
    Article 01 September 2020
  13. Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis

    Background

    Preeclampsia (PE), an obstetric disorder, remains one of the leading causes of maternal and infant mortality worldwide. In individuals with...

    Ermiyas Alemayehu, Ousman Mohammed, ... Hussen Ebrahim in BMC Pregnancy and Childbirth
    Article Open access 13 May 2024
  14. How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation

    Background

    In case of heparin-induced thrombocytopenia (HIT), the switch to a non-heparin anticoagulant is mandatory, at a therapeutic dose. Such a...

    Antoine Barocas, Philippe Savard, ... Emmanuel de Maistre in Thrombosis Journal
    Article Open access 19 September 2023
  15. Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R

    In hemophilia A, bleeding mostly correlates with factor VIII activity (FVIII:C), although some patients show discrepancy in bleeding severity and...

    Ryui Miyashita, Keiko Shinozawa, ... Ei Kinai in International Journal of Hematology
    Article 19 May 2022
  16. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

    Aims/hypothesis

    People with diabetes have an increased cardiovascular risk with an accelerated development of atherosclerosis and an elevated...

    Christina Kohlmorgen, Stephen Gerfer, ... Maria Grandoch in Diabetologia
    Article Open access 16 June 2021
  17. A Potential Role for MAGI-1 in the Bi-Directional Relationship Between Major Depressive Disorder and Cardiovascular Disease

    Purpose of Review

    Major Depressive Disorder (MDD) is characterized by persistent symptoms such as fatigue, loss of interest in activities, feelings of...

    Priyanka Banerjee, Khanh Chau, ... Nhat-Tu Le in Current Atherosclerosis Reports
    Article 03 July 2024
  18. Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant

    Hereditary angioedema due to pathogenic FXII variants (HAE-FXII) is a rare dominant disease caused by increased activation of the plasma contact...

    R. López-Gálvez, M. E. de la Morena-Barrio, ... A. López-Lera in Clinical Reviews in Allergy & Immunology
    Article 16 March 2021
  19. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

    Emicizumab shortens activated partial thromboplastin time (aPTT) greater than Factor (F)VIII. Clot waveform analysis triggered by ellagic acid and...

    Kenichi Ogiwara, Keiji Nogami, ... Midori Shima in International Journal of Hematology
    Article 03 August 2020
Did you find what you were looking for? Share feedback.